Psychological effects of dysphonia in voice professionals

Saltürk, Zıya; Kumral, Tolgar Lütfı; Aydoğdu, İmran; Arslanoğlu, Ahmet; Berkıten, Güler; Yıldırım, Güven; Uyar, Yavuz

doi:10.1002/lary.25319

Cited by 17 publications

(6 citation statements)

References 19 publications

(53 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most obviously, this affects professional musicians 155 . Singers are expectedly more anxious about voice problems 156,157 and often seek health care for symptoms such as vocal fatigue not commonly perceived as dysphonia 158 . However, it cannot be overemphasized that professional voice users form a much broader category that includes any person who relies on her or his voice for an occupation 159 .…”

Section: Guideline Key Action Statementsmentioning

confidence: 99%

Clinical Practice Guideline: Hoarseness (Dysphonia) (Update)

Stachler

Francis

Schwartz

et al. 2018

Otolaryngol.--head neck surg.

225

195

View full text Add to dashboard Cite

Objective. This guideline provides evidence-based recommendations on treating patients who present with dysphonia, which is characterized by altered vocal quality, pitch, loudness, or vocal effort that impairs communication and/or quality of life. Dysphonia affects nearly one-third of the population at some point in its life. This guideline applies to all age groups evaluated in a setting where dysphonia would be identified or managed. It is intended for all clinicians who are likely to diagnose and treat patients with dysphonia.Purpose. The primary purpose of this guideline is to improve the quality of care for patients with dysphonia, based on current best evidence. Expert consensus to fill evidence gaps, when used, is explicitly stated and supported with a detailed evidence profile for transparency. Specific objectives of the guideline are to reduce inappropriate variations in care, produce optimal health outcomes, and minimize harm.For this guideline update, the American Academy of Otolaryngology-Head and Neck Surgery Foundation selected a panel representing the fields of advanced practice nursing, bronchoesophagology, consumer advocacy, family medicine, geriatric medicine, internal medicine, laryngology, neurology, otolaryngology-head and neck surgery, pediatrics, professional voice, pulmonology, and speech-language pathology.Action Statements. The guideline update group made strong recommendations for the following key action statements (KASs): (1) Clinicians should assess the patient with dysphonia by history and physical examination to identify factors where expedited laryngeal evaluation is indicated. These include, but are not limited to, recent surgical procedures involving the head, neck, or chest; recent endotracheal intubation; presence of concomitant neck mass; respiratory distress or stridor; history of tobacco abuse; and whether the patient is a professional voice user. (2) Clinicians should advocate voice therapy for patients with dysphonia from a cause amenable to voice therapy.The guideline update group made recommendations for the following KASs: (1) Clinicians should identify dysphonia in a patient with altered voice quality, pitch, loudness, or vocal effort that impairs communication or reduces quality of life (QOL). (2) Clinicians should assess the patient with dysphonia by history and physical examination for underlying causes of dysphonia and factors that modify management. (3) Clinicians should perform laryngoscopy, or refer to a clinician who can perform laryngoscopy, when dysphonia fails to resolve or improve within 4 weeks or irrespective of duration if a serious underlying cause is suspected. (4) Clinicians should perform diagnostic laryngoscopy, or refer to a clinician who can perform diagnostic laryngoscopy, before prescribing voice therapy and document/communicate the results to the speech-language pathologist (SLP). (5) Clinicians should advocate for surgery as a therapeutic option for patients with dysphonia with conditions amenable to surgical intervention, such as su...

show abstract

Section: Guideline Key Action Statementsmentioning

confidence: 99%

Clinical Practice Guideline: Hoarseness (Dysphonia) (Update)

Stachler

Francis

Schwartz

et al. 2018

Otolaryngol.--head neck surg.

225

195

View full text Add to dashboard Cite

show abstract

“…Therefore, it is possible that females with dysphonia feel more “handicapped” compared to males. Two prior studies have demonstrated significantly greater stress in women with dysphonia compared to men on the Perceived Stress Scale . It is likely that voice disorders are both perceived, and impact individuals differentially in a sex‐specific manner, within a cultural context .…”

Section: Discussionmentioning

confidence: 98%

Sex‐based outcomes in type I thyroplasty for nonparalytic glottic incompetence

et al. 2019

View full text Add to dashboard Cite

Objective: Clinical outcomes for type I Gore-Tex thyroplasty (GMT) for nonparalytic glottic incompetence (GI) have been reported in the literature. Given differences in male and female laryngeal anatomy, sex-based outcomes should also be evaluated. We endeavored to evaluate sex-specific post-GMT voice outcomes.Methods: We performed a retrospective review of patients undergoing GMT for nonparalytic GI. Multidimensional voice outcome measures including voice-related quality of life (VRQOL), Glottal Function Index (GFI), and grade/roughness/breathiness/ asthenia/strain (GRBAS) were analyzed at postoperative time frames: 0 to 3 months, 3 to 9 months, and 9 to 18 months.Results: Eighty-five subjects (43 females, 42 males) with mean age 53.5 undergoing GMT for nonparalytic GI from 2005 to 2017 met inclusion criteria. Etiologies included vocal fold hypomobility (N = 36, 42%), paresis (N = 18, 21%), vocal fold atrophy (N = 17, 20%), and scarring (N = 14, 17%). Females had significantly greater improvement on VRQOL at 0 to 3 months and 9 to 18 months timeframes compared to males, with mean change in VRQOL: 41.3 versus 22.4 (P = 0.0002) and 42.5 versus 20.8 (P = 0.002), respectively. Similarly, women had significantly greater improvement in GFI at 0 to 3 months follow-up (mean difference − 10.8 vs. −4.9, respectively, P = 0.0002). There was no statistically significant sex difference in GRBAS at any followup interval.Conclusion: Following GMT, females had greater improvement in patient-reported voice outcomes in the early postoperative period. No significant difference between sexes was noted in perceptual measures (GRBAS). Sex-specific outcomes should be evaluated for clinical interventions to improve specificity of preoperative counseling.

show abstract

“…This is an important confirmation that the reduction in objective and perceptual vocal quality observed in SLE patients is perceived by them, leading to subjective dissatisfaction. Furthermore, it is a strong indication that SLE-related dysphonic symptoms could potentially have a direct psychological effect on patients [22]. …”

Section: Discussionmentioning

confidence: 99%

Voice disorder in systemic lupus erythematosus

2017

View full text Add to dashboard Cite

Systemic lupus erythematosus (SLE) is a chronic disease characterized by progressive tissue damage. In recent decades, novel treatments have greatly extended the life span of SLE patients. This creates a high demand for identifying the overarching symptoms associated with SLE and developing therapies that improve their life quality under chronic care. We hypothesized that SLE patients would present dysphonic symptoms. Given that voice disorders can reduce life quality, identifying a potential SLE-related dysphonia could be relevant for the appraisal and management of this disease. We measured objective vocal parameters and perceived vocal quality with the GRBAS (Grade, Roughness, Breathiness, Asthenia, Strain) scale in SLE patients and compared them to matched healthy controls. SLE patients also filled a questionnaire reporting perceived vocal deficits. SLE patients had significantly lower vocal intensity and harmonics to noise ratio, as well as increased jitter and shimmer. All subjective parameters of the GRBAS scale were significantly abnormal in SLE patients. Additionally, the vast majority of SLE patients (29/36) reported at least one perceived vocal deficit, with the most prevalent deficits being vocal fatigue (19/36) and hoarseness (17/36). Self-reported voice deficits were highly correlated with altered GRBAS scores. Additionally, tissue damage scores in different organ systems correlated with dysphonic symptoms, suggesting that some features of SLE-related dysphonia are due to tissue damage. Our results show that a large fraction of SLE patients suffers from perceivable dysphonia and may benefit from voice therapy in order to improve quality of life.

show abstract

Psychological effects of dysphonia in voice professionals

Abstract: 4.

Cited by 17 publications

References 19 publications

Clinical Practice Guideline: Hoarseness (Dysphonia) (Update)

Clinical Practice Guideline: Hoarseness (Dysphonia) (Update)

Sex‐based outcomes in type I thyroplasty for nonparalytic glottic incompetence

Voice disorder in systemic lupus erythematosus

Contact Info

Product

Resources

About